title: Enhanced fibronectin expression is associated with the development of graft arteriosclerosis in human renal allografts.
authors.affiliation: Department of Urology, Osaka City University Medical School, Japan.
authors.forename: S
authors.initials: S
authors.lastname: Tanabe
authors.forename: M
authors.initials: M
authors.lastname: Ueda
authors.forename: Y S
authors.initials: YS
authors.lastname: Han
authors.forename: T
authors.initials: T
authors.lastname: Nakatani
authors.forename: T
authors.initials: T
authors.lastname: Kishimoto
authors.forename: S
authors.initials: S
authors.lastname: Suzuki
authors.forename: H
authors.initials: H
authors.lastname: Amemiya
mesh_terms: D000199:Actins / Q000032:analysis; D000328:Adult; D000911:Antibodies, Monoclonal; D001161:Arteriosclerosis / Q000473:pathology*; D001402:B-Lymphocytes / Q000276:immunology / Q000473:pathology; D005260:Female; D005353:Fibronectins / Q000032:analysis* / Q000096:biosynthesis; D005500:Follow-Up Studies; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D009392:Nephrectomy; D006435:Renal Dialysis; D013601:T-Lymphocytes / Q000276:immunology / Q000473:pathology; D013997:Time Factors; D014184:Transplantation, Homologous; D014746:Vimentin / Q000032:analysis; D014841:von Willebrand Factor / Q000032:analysis
chemical_list: D000199:Actins; D000911:Antibodies, Monoclonal; D005353:Fibronectins; D014746:Vimentin; D014841:von Willebrand Factor